Moderna (MRNA) Insider Trading & Ownership $27.68 -0.46 (-1.63%) Closing price 04:00 PM EasternExtended Trading$27.76 +0.09 (+0.31%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Moderna (NASDAQ:MRNA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.00%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$44.25M Get MRNA Insider Trade Alerts Want to know when executives and insiders are buying or selling Moderna stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MRNA Insider Buying and Selling by Quarter Moderna Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/10/2025Ro KhannaU.S. Congress Member (D-CA)Sell$24.50$1,001 - $15,0004/8/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Sell$24.64$1,001 - $15,0002/25/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Buy$33.22$1,001 - $15,0001/15/2025Julie JohnsonU.S. Congress Member (D-TX)Sell$34.77$1,001 - $15,00012/9/2024Shannon Thyme KlingerInsiderSell529$44.68$23,635.72 12/3/2024Shannon Thyme KlingerInsiderSell112$43.30$4,849.60 12/3/2024Stephen HogePresidentSell314$43.30$13,596.20 11/29/2024Shannon Thyme KlingerInsiderSell1,418$42.79$60,676.22 11/29/2024Stephen HogePresidentSell291$42.79$12,451.89 10/7/2024James M MockCFOSell715$60.12$42,985.80 9/3/2024Shannon Thyme KlingerInsiderSell114$76.99$8,776.86 9/3/2024Stephen HogePresidentSell318$76.99$24,482.82 8/29/2024Shannon Thyme KlingerInsiderSell162$78.03$12,640.86 8/29/2024Stephen HogePresidentSell300$78.03$23,409.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/28/2024James M MockCFOSell1,321$79.39$104,874.19 8/12/2024Stephen HogePresidentSell254$84.10$21,361.40 7/31/2024Noubar AfeyanDirectorSell15,000$119.96$1,799,400.00 7/24/2024Noubar AfeyanDirectorSell15,000$117.80$1,767,000.00 7/17/2024Noubar AfeyanDirectorSell15,000$122.84$1,842,600.00 7/15/2024Stephen HogePresidentSell15,000$121.12$1,816,800.00 7/10/2024Noubar AfeyanDirectorSell15,000$117.08$1,756,200.00 7/8/2024James M MockCFOSell689$118.24$81,467.36 6/26/2024Noubar AfeyanDirectorSell15,000$127.22$1,908,300.00 6/17/2024Stephen HogePresidentSell15,000$138.16$2,072,400.00 6/11/2024Noubar AfeyanDirectorSell202,832$148.34$30,088,098.88 6/10/2024Shannon Thyme KlingerInsiderSell5,178$148.09$766,810.02 (Data available from 1/1/2013 forward) MRNA Insider Trading Activity - Frequently Asked Questions Who is on Moderna's Insider Roster? The list of insiders at Moderna includes Arpa Garay, David W Meline, James M Mock, Juan Andres, Noubar Afeyan, Shannon Thyme Klinger, Stephane Bancel, and Stephen Hoge. Learn more on insiders at MRNA. What percentage of Moderna stock is owned by insiders? 11.00% of Moderna stock is owned by insiders. Learn more on MRNA's insider holdings. Which Moderna insiders have been selling company stock? The following insiders have sold MRNA shares in the last 24 months: Arpa Garay ($44,183.76), James M Mock ($845,327.35), Noubar Afeyan ($90,846,148.88), Shannon Thyme Klinger ($1,322,260.31), Stephane Bancel ($13,227,662.65), and Stephen Hoge ($23,473,815.03). How much insider selling is happening at Moderna? Insiders have sold a total of 1,071,007 Moderna shares in the last 24 months for a total of $129,759,397.98 sold. Which members of congress are trading Moderna? Robert Bresnahan, Jr. (R-PA) has bought shares of Moderna in the last year totaling $8,000. Ro Khanna (D-CA), Robert Bresnahan, Jr. (R-PA), and Julie Johnson (D-TX) have sold shares totaling $24,000. Moderna Key ExecutivesMr. Stephane Bancel (Age 51)Chief Executive Officer Compensation: $4.55MDr. Stephen Hoge M.D. (Age 47)President Compensation: $1.92MMr. James M. Mock (Age 47)Chief Financial Officer Compensation: $1.4MMs. Shannon Thyme Klinger (Age 53)Chief Legal Officer & Corporate Secretary Compensation: $1.39MDr. Jerh Collins Ph.D. (Age 57)Chief Technical Operations & Quality Officer Mr. Brad Miller (Age 50)Chief Information Officer Ms. Lavina Talukdar CFASenior VP & Head of Investor RelationsColleen HusseySenior Director of Corporate CommunicationsMs. Tracey Franklin (Age 43)Chief Human Resources Officer Dr. Melanie Ivarsson M.B.A.Ph.D., Chief Development Officer More Insider Trading Tools from MarketBeat Related Companies argenx Insider Trades Beigene Insider Trades BioNTech Insider Trades Teva Pharmaceutical Industries Insider Trades Summit Therapeutics Insider Trades Genmab A/S Insider Trades Intra-Cellular Therapies Insider Trades Viatris Insider Trades Blueprint Medicines Insider Trades Roivant Sciences Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders BoughtMeta's Institutional & Insider Data Fuels Bulls Despite Disparity This page (NASDAQ:MRNA) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
